JD Health International Inc. American Depositary Receipt (8ZN1)
FSX
3.86
+0.16 (+4.32%)
Closed
Oct 8, 2026
Day's Range
3.863.86
52 wk Range
3.447.55
Financial Statements - 8ZN1 - JD Health International Inc. American Depositary Receipt
Revenue
73.44B▲ 26.3%
Net Income
5.36B▲ 29.1%Net Margin 7.3%
EBITDA
6.46B▲ 21.2%
Free Cash Flow
10.02B▲ 133.9%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Sales | 73.44B | 58.15B | 53.52B | 46.73B |
| Cost of Goods | 55.24B | 44.85B | 41.66B | 36.84B |
| Gross Profit | 18.19B | 13.30B | 11.86B | 9.89B |
 Operating Expense | - | - | - | - |
| Operating Income | 3.94B | 1.47B | 700.70M | -46.91M |
| Non-Operating Interest | - | - | - | - |
| Other Income Expense | - | - | - | - |
| Pre Tax Income | 6.02B | 4.79B | 2.69B | 695.80M |
| Income Tax | 662.88M | 639.66M | 550.46M | 312.58M |
| Net Income | 5.36B | 4.15B | 2.14B | 383.22M |
| EPS Basic | 1.79 | 1.32 | 0.69 | 0.12 |
| EPS Diluted | 1.68 | 1.32 | 0.68 | 0.12 |
| Basic Shares Outstanding | 3.16B | 3.14B | 3.12B | 3.10B |
| Diluted Shares Outstanding | 3.16B | 3.14B | 3.12B | 3.10B |
| Ebit | 6.04B | 4.80B | 2.70B | 704.90M |
| Ebitda | 6.46B | 5.33B | 3B | 943.78M |
| Net Income Continuous Operations | 5.36B | 4.15B | 2.14B | 383.22M |
| Minority Interests | 8.29M | 4.83M | -1.03M | -3.12M |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
